Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 431-440 of 603 for hematology

Edit search filters
  1. A Study To Investigate The Safety And Tolerability Of REGN1979 In Patients With CD20+ B-Cell Malignancies

    Rochester, MN

  2. A Study Of Copanlisib And Nivolumab In Treating Participants With Recurrent Or Refractory Diffuse Large B-cell Lymphoma Or Primary Mediastinal Large B-cell Lymphoma

    Rochester, MN

  3. A Study To Evaluate Itacitinib For Low Risk Graft-vs-Host Disease (GVHD)

    Rochester, MN

  4. Study Of The Safety, Pharmacokinetics And Efficacy Of EDO-S101, In Patients With Advanced Solid Tumors

    Scottsdale/Phoenix, AZ, Rochester, MN

  5. A Study To Evaluate MesilatE For Treating Hospitalized Patients With COVID-19 (Enrolling By Invitation Only)

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  6. Dose-Reduced Consolidation Radiation Therapy In Patients With Diffuse Large B-cell Lymphoma (DLBCL)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  7. Study Of Bcl-2 Inhibitor BGB-11417 In Participants With Mature B-Cell Malignancies

    Rochester, MN

  8. A Study To Evaluate At Home Administration Of Pertuzumab Combined With Trastuzumab To Treat Patients With HER2-Positive Breast Cancer During COVID-19 Pandemic

    Jacksonville, FL, Rochester, MN

  9. Study Of Lenzilumab And Axicabtagene Ciloleucel In Subjects With Relapsed Or Refractory Large B-cell Lymphoma

    Rochester, MN

  10. Study Of Iopofosine I 131 (CLR 131) In Select B-Cell Malignancies (CLOVER-1) And Pivotal Expansion In Waldenstrom Macroglobulinemia (CLOVER-WaM)

    Jacksonville, FL

.

Mayo Clinic Footer